The FINANCIAL -- GlaxoSmithKline plc announced that it has reached agreement to divest the majority of its “Classic Brands” in Australia to Aspen Global Incorporated for approximately £172 million in cash. 

The FINANCIAL -- Pfizer announced that it has entered into an agreement with AstraZeneca for the over-the-counter rights for NEXIUM, one of a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).

The FINANCIAL -- The Chrysler brand and BabyCenter LLC, the 1 pregnancy and parenting mobile and web destination worldwide, today announced a partnership to highlight the 2012 Chrysler Town & Country minivan's standard luxury features, quality, and value to millions of moms across the country.

The FINANCIAL -- Pfizer Inc. announced that the Phase 3 INTORACT trial, evaluating the combination of bevacizumab plus TORISEL compared with bevacizumab plus interferon-alfa-2a in the first-line treatment of patients with advanced renal cell carcinoma across risk groups, did not meet its primary endpoint of superiority in extending progression free survival in the study population.

The FINANCIAL -- In a landmark discovery, researchers from Crucell Holland B.V. and The Scripps Research Institute, today announced the identification of the first human monoclonal antibodies that appear capable of disabling all influenza B viruses.